We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
Updated: 4/26/2017
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment
Status: Enrolling
Updated: 4/26/2017
Click here to add this to my saved trials
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Updated: 5/2/2017
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Updated: 5/2/2017
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Click here to add this to my saved trials
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Updated: 5/2/2017
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Updated: 5/2/2017
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Click here to add this to my saved trials
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated: 5/2/2017
Click here to add this to my saved trials
Time to Conceive: A Study of Fertility
Updated: 5/3/2017
Time to Conceive: A Study of Fertility: Biomarkers of Fertility
Status: Enrolling
Updated: 5/3/2017
Time to Conceive: A Study of Fertility
Updated: 5/3/2017
Time to Conceive: A Study of Fertility: Biomarkers of Fertility
Status: Enrolling
Updated: 5/3/2017
Click here to add this to my saved trials
The Effect of a Coloring Prompt on Health Engagement
Updated: 5/3/2017
The Effect of a Coloring Prompt on Health Engagement
Status: Enrolling
Updated: 5/3/2017
The Effect of a Coloring Prompt on Health Engagement
Updated: 5/3/2017
The Effect of a Coloring Prompt on Health Engagement
Status: Enrolling
Updated: 5/3/2017
Click here to add this to my saved trials
Pelvic Examination in Pregnancy
Updated: 5/3/2017
Utility of Pelvic Examination in the Evaluation of Threatened Abortion
Status: Enrolling
Updated: 5/3/2017
Pelvic Examination in Pregnancy
Updated: 5/3/2017
Utility of Pelvic Examination in the Evaluation of Threatened Abortion
Status: Enrolling
Updated: 5/3/2017
Click here to add this to my saved trials
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis
Updated: 5/3/2017
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis
Status: Enrolling
Updated: 5/3/2017
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis
Updated: 5/3/2017
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis
Status: Enrolling
Updated: 5/3/2017
Click here to add this to my saved trials
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
Updated: 5/4/2017
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
Status: Enrolling
Updated: 5/4/2017
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
Updated: 5/4/2017
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
Status: Enrolling
Updated: 5/4/2017
Click here to add this to my saved trials
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Updated: 5/5/2017
A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Status: Enrolling
Updated: 5/5/2017
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Updated: 5/5/2017
A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Status: Enrolling
Updated: 5/5/2017
Click here to add this to my saved trials
Hydrolized Protein Formula for Premature Infants
Updated: 5/9/2017
Randomized Trial of Hydrolyzed Protein Premature Formula
Status: Enrolling
Updated: 5/9/2017
Hydrolized Protein Formula for Premature Infants
Updated: 5/9/2017
Randomized Trial of Hydrolyzed Protein Premature Formula
Status: Enrolling
Updated: 5/9/2017
Click here to add this to my saved trials
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
Updated: 5/9/2017
A Placebo Controlled Double Blinded Prospective Study to Investigate the Usefulness of Omega 3 Fatty Acids in the Relief of Vasomotor Symptoms of Menopausal Women
Status: Enrolling
Updated: 5/9/2017
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
Updated: 5/9/2017
A Placebo Controlled Double Blinded Prospective Study to Investigate the Usefulness of Omega 3 Fatty Acids in the Relief of Vasomotor Symptoms of Menopausal Women
Status: Enrolling
Updated: 5/9/2017
Click here to add this to my saved trials
Human Milk Fortifier and Cytokine Profile
Updated: 5/9/2017
Alterations in the Cytokine Profile of Premature Infants After Human Milk Fortifier
Status: Enrolling
Updated: 5/9/2017
Human Milk Fortifier and Cytokine Profile
Updated: 5/9/2017
Alterations in the Cytokine Profile of Premature Infants After Human Milk Fortifier
Status: Enrolling
Updated: 5/9/2017
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)
Updated: 5/10/2017
To Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) Co-administered With EFAVIRENZ
Status: Enrolling
Updated: 5/10/2017
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)
Updated: 5/10/2017
To Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) Co-administered With EFAVIRENZ
Status: Enrolling
Updated: 5/10/2017
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause
Updated: 5/11/2017
Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause
Status: Enrolling
Updated: 5/11/2017
Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause
Updated: 5/11/2017
Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Skin Lipid Profiles in Term and Preterm Infants
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Status: Enrolling
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Status: Enrolling
Updated: 5/18/2017
Click here to add this to my saved trials
Skin Lipid Profiles in Term and Preterm Infants
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Status: Enrolling
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Updated: 5/18/2017
Skin Lipid Profiles in Term and Preterm Infants
Status: Enrolling
Updated: 5/18/2017
Click here to add this to my saved trials
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
Status: Enrolling
Updated: 6/8/2017
Updated: 6/8/2017
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
Status: Enrolling
Updated: 6/8/2017
Updated: 6/8/2017
Click here to add this to my saved trials
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
Updated: 6/8/2017
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
Status: Enrolling
Updated: 6/8/2017
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
Updated: 6/8/2017
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
Updated: 6/8/2017
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
Status: Enrolling
Updated: 6/8/2017
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
Updated: 6/8/2017
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Validation Study for Robotic Surgery Simulator
Updated: 6/8/2017
Validation Study for Robotic Surgery Simulator
Status: Enrolling
Updated: 6/8/2017
Validation Study for Robotic Surgery Simulator
Updated: 6/8/2017
Validation Study for Robotic Surgery Simulator
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy
Updated: 6/8/2017
Prospective Cohort Study Comparing Two Lightweight Y Meshes After Robotic-Assisted Laparoscopic Sacrocolpopexy Longterm Outcomes
Status: Enrolling
Updated: 6/8/2017
Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy
Updated: 6/8/2017
Prospective Cohort Study Comparing Two Lightweight Y Meshes After Robotic-Assisted Laparoscopic Sacrocolpopexy Longterm Outcomes
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction
Updated: 6/15/2017
Outpatient Foley Catheter Compared to Usual Inpatient Care for Cervical Ripening: a Randomized Controlled Trial
Status: Enrolling
Updated: 6/15/2017
Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction
Updated: 6/15/2017
Outpatient Foley Catheter Compared to Usual Inpatient Care for Cervical Ripening: a Randomized Controlled Trial
Status: Enrolling
Updated: 6/15/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Click here to add this to my saved trials
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Click here to add this to my saved trials
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Early Elimination of Premature Ventricular Contractions in Heart Failure
Updated: 6/20/2017
EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.
Status: Enrolling
Updated: 6/20/2017
Click here to add this to my saved trials